Align Technology | ALGN - Ordinary Share Capital


Align Technology reported $71.04M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
3M USD 516.73M 1.01M Sep/2026
Align Technology USD 71.04M 578K Sep/2026
Becton, Dickinson and Co. USD 272.39M 98.21M Sep/2026
Bruker USD 152.35M 130K Jun/2026
Cardinal Health USD 232M 1000K Sep/2026
Charles River Laboratories USD 47.88M 148K Sep/2026
Cooper Companies USD 190.1M 5.01M Jun/2026
CVS Health USD 1.28B 2M Sep/2026
Danaher USD 703.4M 500K Sep/2026
Dentsply International USD 198.2M 1000K Sep/2026
Dexcom USD 377.4M 8.5M Jun/2026
Henry Schein USD 110.54M 1.38M Sep/2026
Idexx Laboratories USD 78.78M 93K Sep/2026
Insulet USD 69.37M 16K Sep/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
McKesson USD 115M 1000K Sep/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Revvity USD 111.59M 43K Sep/2026
Solventum Corp USD 169.96M 156.65K Sep/2026
Stryker USD 383.4M 416K Jun/2026
Teleflex USD 42.37M 1.89M Jun/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Veeva Systems USD 162.44M 756K Jun/2026
Waters USD 98.19M 20K Jun/2026
Zimmer Biomet Holdings USD 190.1M 3.3M Sep/2026
Zoetis USD 407.49M 6.67M Sep/2026